In these cell lines, alpelisib inhibited cell growth with various IC50 values, ranging from 25 to 160 μM (Supplementary Fig. S2), supporting the general toxicity of the PIK3CA inhibitor towards HCC cell lines. The gene discussed is PIK3CA; the disease is hepatocellular carcinoma.